Garvan News Findings that should speed the development of drugs for Parkinson’s DiseaseMEDIA RELEASE: 18 Nov 2009 Neuroscientists at Garvan have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson’s Disease. MoreNew findings connect diet and intestinal bacteria with healthier immune systemsMEDIA RELEASE: 29 Oct 2009 Insoluble dietary fibre, or roughage, not only keeps you regular, there is evidence to suggest it also plays a vital role in keeping many diseases at bay. Published tomorrow in Nature, breakthrough research by a Garvan team describes a mechanism that links diet, gut bacteria and the immune system. MoreResearch Fellowship announcement to support link between weight loss and the reversal of Type 2 diabetesMEDIA RELEASE: 27 Oct 2009 Associate Professor Katherine Samaras is the new recipient of the GlaxoSmithKline (GSK) Don Chisholm Diabetes Research Fellowship. The Fellowship is dedicated to funding vital research into the causes, processes and treatments for Type 2 diabetes, one of Australia’s most common and serious diseases – and is named in honour of Professor Don Chisholm, who is recognised as a leader in clinical diabetes research. MoreThe genetic fuse that may ignite Type 1 diabetesMEDIA RELEASE: 20 Oct 2009 Garvan scientists have discovered that a tiny genetic irregularity, which boosts the expression of a key gene, may lead to the development of Type 1 diabetes. While there is no cure yet, prevention therapies are on the horizon, making the development of reliable screening tools critical. And that's where the current finding has promise. MoreThe free radical that triggers insulin resistance and Type 2 diabetesMEDIA RELEASE: 28 Sep 2009 Garvan scientists have found that overeating may stimulate the conversion of the oxygen in the air we breathe into toxic free radicals, leading to insulin resistance and Type 2 diabetes. Until now, no-one has identified the central mechanism, or cellular switch, that initiates insulin resistance. MoreHow coconut oil could help reduce the symptoms of Type 2 diabetesMEDIA RELEASE: 08 Sep 2009 A new study in animals demonstrates that a diet rich in coconut oil protects against ‘insulin resistance’ in muscle and fat. It also avoids the accumulation of body fat caused by other high fat diets of similar calorie content – although can cause fat build up in the liver. These findings are important because obesity and insulin resistance are major factors leading to the development of Type 2 diabetes. MoreEpigenetics featured in NHMRC ‘Ten of the Best Research Projects 2009’17 Aug 2009 The work of Garvan’s Professor Susan Clark is featured in the NHMRC (National Health and Medical Research Council) 10 of the Best Research Projects 2009 booklet, launched this morning in Canberra. Of the hundreds of research projects funded by the NHMRC each year, the booklet highlights those that best help combat some of the nation’s biggest health challenges. MoreGarvan welcomes promising results for new lupus drugMEDIA RELEASE: 13 Aug 2009 Garvan scientists have welcomed recent news that a late-stage clinical trial of the lupus drug belimumab has shown highly promising results. If approved, it will be the first new treatment for lupus, or systemic lupus erythematosus (SLE), in decades. More |
Events Young Garvan presents: "THE SPIRIT OF SCIENCE"03 Dec 2009
Young Garvan
2009 Garvan International Fellow Symposium: Diabetes and obesity: current concepts and future directions14 Dec 2009
Scientific
2009 Garvan International Fellow Lecture: My Genes Made Me Eat That!15 Dec 2009
Public Seminar
Garvan International Fellow Symposium 2009 Internationally renowned speakers will discuss the very latest developments in diabetes and obesity research. Download flyer. Registration is
free but essential. Click here for further details and to
register. Garvan St. Vincent's Cancer Centre "Please help us raise the funds we need to build this wonderful new facility to bring research and care together under one roof" Delta Goodrem, Centre Patron
For more information visit the Cancer Centre website. Garvan Links TOUR GARVAN
FRACTURE RISK CALCULATORBased on data from the 18-year Dubbo Osteoporosis Epidemiology Study. For men and women 60 years and over to assess their individual risk of fracture. www.fractureriskcalculator.com
AUSTRALIAN PANCREATIC CANCER GENOME INITIATIVEGarvan is involved in the Australian arm of the The International Cancer Genome Consortium – by investigating pancreatic cancer. For more information click here. |
